POOLBEG PHARMA LS -,0002POOLBEG PHARMA LS -,0002POOLBEG PHARMA LS -,0002

POOLBEG PHARMA LS -,0002

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪28.51 M‬EUR
−0.0105EUR
‪−4.53 M‬EUR
0.00EUR
‪425.26 M‬
Beta (1Y)
0.81

About POOLBEG PHARMA PLC ORD GBP0.0002


CEO
Jeremy Skillington
Headquarters
London
Founded
2021
ISIN
GB00BKPG7Z60
FIGI
BBG011WSQX53
Poolbeg Pharma Plc is a clinical-stage infectious disease pharmaceutical company. The firm's capital light clinical model enables to develop multiple products faster than the traditional biotech model. Its portfolio includes POLB 001, Phase II ready, repositioned small molecule immunomodulatory for severe influenza, along with a vaccine discovery platform, PredictViral biomarker platform, and the disease progression data & bio banks that will be interrogated using AI platforms. The company was founded on March 19, 2021 and is headquartered in London, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange POOLBEG PHARMA LS -,0002 stocks are traded under the ticker 7JN.
We've gathered analysts' opinions on POOLBEG PHARMA LS -,0002 future price: according to them, 7JN price has a max estimate of 0.22 EUR and a min estimate of 0.22 EUR. Watch 7JN chart and read a more detailed POOLBEG PHARMA LS -,0002 stock forecast: see what analysts think of POOLBEG PHARMA LS -,0002 and suggest that you do with its stocks.
7JN reached its all-time high on May 8, 2024 with the price of 0.1750 EUR, and its all-time low was 0.0100 EUR and was reached on Jul 21, 2021. View more price dynamics on 7JN chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track POOLBEG PHARMA LS -,0002 financials in yearly and quarterly reports right on TradingView.
POOLBEG PHARMA LS -,0002 is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
7JN net income for the last half-year is ‪−2.67 M‬ EUR, while the previous report showed ‪−2.45 M‬ EUR of net income which accounts for −9.00% change. Track more POOLBEG PHARMA LS -,0002 financial stats to get the full picture.
No, 7JN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 7JN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade POOLBEG PHARMA LS -,0002 stock right from TradingView charts — choose your broker and connect to your account.